Parallel import of human medicines with Danish labeling as well as development and distribution of generics.

2care4 ApS

Esbjerg (DK) · Köln (DE) · Stockholm (SE) · Pabianice (PL)New on Amplifa

2005Founded

300+Employees (Group, Europe)

4Locations in Europe

About 2care4

The 2care4 Group was founded in 2005 in Esbjerg and has been active in the parallel import of human medicines within EU/EEA countries since then. Parallel import involves sourcing original medicines from other EU/EEA countries and repackaging and labeling them to meet Danish requirements. Since 2010, the company has also been involved in the development and trade of generics; the first generic (Etodolac) was launched in 2013. Repackaging is carried out in accordance with the principles of good manufacturing practice (GMP) and is subject to regular inspections by the Danish Medicines Agency (Lægemiddelstyrelsen). The group employs more than 300 people across Europe and supplies the Scandinavian and German pharmaceutical markets. Only approved, qualified suppliers and carriers are admitted into the supply chain; quality assurance is ensured through a pharmaceutical quality system.

Site: DK-6710 Esbjerg
Processes: Parallel import of human medicines (EU/EEA) including repackaging with Danish labeling, Development and distribution of generics, Supply to pharmacies, Supplier and carrier qualification (Supply Chain Quality Assurance), Pharmaceutical quality system
Materials: Parallel import of human medicines, Generic Development and Distribution, Pharmaceutical Quality System
Certificates: GMP (Drug Repackaging, regular inspections by Danish, GMP (Drug Repackaging, Danish Medicines Agency)
Founded: 2005
Employees: 300+ (Group,
Industries: Pharma/Medicines (Parallel import, Generics), Markets: Scandinavia and Germany

01
Sourcing original medicines from approved EU/EEA wholesalers
02
Supplier and carrier qualification
03
Goods receipt inspection and quarantine in case of discrepancies
04
Repackaging and labeling (Danish text)
05
Quality check and release
06
Delivery to pharmacies

Services and Processes

Parallel import of human medicines

Import of original medicines from EU/EEA countries including repackaging with Danish labeling.

GEN

Generic Development and Distribution

Development and distribution of generics for Scandinavian and German markets.

Pharmaceutical Quality System

Documented processes, training, and independent quality assessment of repackaging processes.

Sites

Esbjerg

Headquarters (2care4 ApS / 2care4 Generics ApS)

Materials: Parallel import, Generics

Köln

2care4 GmbH, German market

Stockholm

2care4 Sweden, Office

Pabianice

2care4 Poland

Inside the production

Industries

Pharma/Medicines (Parallel import, Generics)Markets: Scandinavia and Germany

Additional services

Parallel import of human medicines (EU/EEA) including repackaging with Danish labelingDevelopment and distribution of genericsSupply to pharmaciesSupplier and carrier qualification (Supply Chain Quality Assurance)Pharmaceutical quality system

Quality

2care4 operates according to a pharmaceutical quality system (GMP) and is regularly inspected by the Danish Medicines Agency (Lægemiddelstyrelsen). Goods receipt control, documented repackaging, independent quality assessment, and release by authorized personnel ensure product safety.

Evidence	Esbjerg
GMP (Drug Repackaging, Danish Medicines Agency)

History

2005
Foundations of 2care4 in Esbjerg; focus on parallel import of medicines
2010
Entry into generic development and trade
2013
Launch of the first generic (Etodolac) by 2care4 ApS